Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

60 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   5-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride   -   -   -   -   [1]
20 
 2   Acetylcysteine   Acetylcysteine   D00221   -   -   [14]
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 3   Alemtuzumab   Alemtuzumab   D02802   -   -   [13]
13,
15,
19,
20,
46,
51,
60,
63,
65,
85,
96,
164,
284 
 4   Autologous cd34+ cells transduced with lenti-d vector encoding abcd1 cdna   -   -   -   -   [1]
20 
 5   Autologous haematopoietic stem cells transduced with lentiviral vector lenti-d encoding the human abcd1 cdna   -   -   -   -   [1]
20 
 6   Bezafibrate   Bezafibrate   D01366   [1] PPARA   [7] Adipocytokine signaling pathway, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease (NAFLD), PPAR signaling pathway, cAMP signaling pathway   [5]
20,
93,
94,
160,
316 
 7   Biotin   Biotin   D00029   -   -   [3]
2,
13,
20 
 8   Busulfan   Busulfan   D00248   -   -   [13]
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326 
 9   Busulfan, cyclophosphamide, antithymocyte globulin   Cyclophosphamide   D00287, D07760   -   -   [2]
19,
20 
 10   Cald hr-d (high-risk, regimen c)   -   -   -   -   [4]
19,
20,
234,
326 
 11   Cald hr-d (high-risk, regimen d)   -   -   -   -   [4]
19,
20,
234,
326 
 12   Cald sr-a (standard-risk, regimen a)   -   -   -   -   [4]
19,
20,
234,
326 
 13   Cald sr-b (standard-risk, regimen b)   -   -   -   -   [4]
19,
20,
234,
326 
 14   Campath-1h   Alemtuzumab   D02802   -   -   [6]
19,
20,
60,
234,
285,
326 
 15   Chenodeoxycholic acid   Chenodeoxycholic acid   D00163   [1] NR1H4   [1] Bile secretion   [4]
20,
96,
234,
263 
 16   Cholic acid   Cholic acid   D10699   [1] NR1H4   [1] Bile secretion   [4]
20,
234,
265,
310 
 17   Cholic acids   -   -   -   -   [2]
20,
234 
 18   Clofarabine   Clofarabine   D03546   [3] POLA1, POLA2, RRM1   [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   [9]
19,
20,
40,
46,
49,
60,
96,
234,
326 
 19   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   [43]
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 20   Cyclosporine   Ciclosporin   D00184   [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   [30] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   [33]
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 21   Cyclosporine a   Ciclosporin   D00184   [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   [30] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   [8]
19,
20,
36,
49,
53,
58,
60,
234 
 22   D-biotin   Biotin   D00029   -   -   [2]
13,
20 
 23   Duoc-01   -   -   -   -   [2]
19,
20 
 24   Genetic   -   -   -   -   [1]
20 
 25   Glyceryl trierucate   Glyceryl trierucate   -   -   -   [1]
20 
 26   Glyceryl trioleate   Glyceryl trioleate   -   -   -   [1]
20 
 27   Hematopoietic stem cell infusion   -   -   -   -   [2]
19,
20 
 28   Hematopoietic stem cell transplantation   -   -   -   -   [12]
11,
13,
14,
19,
20,
35,
46,
49,
51,
96,
234,
285 
 29   Human placental derived stem cell   -   -   -   -   [4]
19,
20,
60,
284 
 30   Hydroxyurea   Hydroxyurea   D00341   [1] RRM2   [6] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway   [8]
3,
13,
19,
20,
65,
85,
86,
284 
 31   Imd preparative regimen   -   -   -   -   [4]
19,
20,
234,
326 
 32   Interferon beta   Human interferon beta   -   -   -   [6]
13,
14,
20,
26,
96,
97 
 33   Lenti-d drug product   -   -   -   -   [1]
20 
 34   Lipoic acid   Lipoic acid   D00048, D00086   -   -   [5]
2,
5,
13,
14,
20 
 35   Lorenzo's oil   -   -   -   -   [1]
20 
 36   Md1003   -   -   -   -   [5]
2,
10,
13,
14,
20 
 37   Md1003 100 mg capsule   -   -   -   -   [1]
20 
 38   Melphalan   Melphalan   D00369   -   -   [14]
11,
13,
14,
19,
20,
28,
60,
62,
65,
96,
164,
234,
284,
285 
 39   Mesenchymal stem cells   -   -   -   -   [11]
2,
6,
13,
20,
49,
51,
60,
96,
222,
274,
299 
 40   Min-102   -   -   -   -   [1]
20 
 41   Modified cobratoxin   -   -   -   -   [1]
20 
 42   Mycophenolate   Mycophenolic acid   D05096   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [33]
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 43   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   [2] IMPDH1, IMPDH2   [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   [32]
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 44   Mycophenylate mofetil   -   -   -   -   [2]
19,
20 
 45   N-acetylcysteine   Acetylcysteine   D00221   -   -   [10]
6,
13,
19,
20,
49,
58,
85,
111,
164,
299 
 46   Osteopetrosis haploidentical only preparative regimen   -   -   -   -   [4]
19,
20,
234,
326 
 47   Osteopetrosis only preparative regimen   -   -   -   -   [4]
19,
20,
234,
326 
 48   Pioglitazone   Pioglitazone   D00945, D08378   [1] PPARG   [9] AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer   [17]
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299 
 49   Rpi78m   Rpi78m   -   -   -   [1]
20 
 50   Rpi78m for injection   Rpi78m   -   -   -   [1]
20 
 51   Sobetirome   Sobetirome   D09381   [1] THRB   [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway   [1]
20 
 52   Sobetirome (nv1205)   Sobetirome   D09381   [1] THRB   [2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway   [1]
20 
 53   Stem cell transplantation   -   -   -   -   [9]
13,
19,
20,
46,
65,
90,
164,
234,
326 
 54   Thalidomide   Thalidomide   D00754   [1] TNF   [61] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis (ALS), Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease (American trypanosomiasis), Cytokine-cytokine receptor interaction, Dilated cardiomyopathy (DCM), Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy (HCM), IL-17 signaling pathway, Inflammatory bowel disease (IBD), Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease (NAFLD), Osteoclast differentiation, Pathogenic Escherichia coli infection, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway   [18]
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 55   Thiotepa   Thiotepa   D00583   -   -   [11]
13,
19,
20,
28,
51,
60,
65,
85,
96,
164,
284 
 56   Thiotepa--escalated dose   Thiotepa   D00583   -   -   [4]
19,
20,
65,
284 
 57   Thiotepa--single daily dose   Thiotepa   D00583   -   -   [4]
19,
20,
65,
284 
 58   Ursodiol   Ursodeoxycholic acid   D00734   [1] NR1H4   [1] Bile secretion   [6]
8,
20,
93,
97,
234,
299 
 59   Vitamin d3   Cholecalciferol   D00188   [1] VDR   [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   [11]
6,
13,
20,
46,
49,
53,
60,
65,
96,
97,
299 
 60   Vitamin e   Vitamin e   D02331   -   -   [11]
2,
6,
13,
20,
46,
90,
96,
97,
206,
299,
317 

Back to top